Literature DB >> 29337374

Pooled Lentiviral-Delivery Genetic Screens.

Federica Piccioni1, Scott T Younger1, David E Root1.   

Abstract

Pooled cell-based screens of mammalian genetic perturbations enable systematic large-scale, even genome-scale, evaluation of gene function. Pooled screens introduce genetic perturbations into a cell population through viral transduction such that each cell integrates into its DNA a single or small number of library perturbations with barcodes identifying the perturbations. One then selects and physically isolates the subset of cells that exhibit the phenotype of interest. Sequencing the barcodes in the hit cells reveals which genes favored or inhibited the hit phenotype. Various genetic perturbations are possible, including CRISPR gene knockout, ectopic gene expression, and RNA interference. Regardless of the type of library being screened or the type of cell model being tested, such screens involve many common steps and procedures. This unit describes detailed experimental protocols for the key steps, and also highlights some of the key factors to achieving a well-powered, reproducible screen result. © 2018 by John Wiley & Sons, Inc.
Copyright © 2018 John Wiley & Sons, Inc.

Entities:  

Keywords:  CRISPR screens; functional genomics; large-scale genetic screens; pooled screens

Mesh:

Year:  2018        PMID: 29337374     DOI: 10.1002/cpmb.52

Source DB:  PubMed          Journal:  Curr Protoc Mol Biol        ISSN: 1934-3647


  10 in total

1.  Pooled Genomic Screens Identify Anti-apoptotic Genes as Targetable Mediators of Chemotherapy Resistance in Ovarian Cancer.

Authors:  Elizabeth H Stover; Maria B Baco; Ofir Cohen; Yvonne Y Li; Elizabeth L Christie; Mukta Bagul; Amy Goodale; Yenarae Lee; Sasha Pantel; Matthew G Rees; Guo Wei; Adam G Presser; Maya K Gelbard; Weiqun Zhang; Ioannis K Zervantonakis; Patrick D Bhola; Jeremy Ryan; Jennifer L Guerriero; Joan Montero; Felice J Liang; Andrew D Cherniack; Federica Piccioni; Ursula A Matulonis; David D L Bowtell; Kristopher A Sarosiek; Anthony Letai; Levi A Garraway; Cory M Johannessen; Matthew Meyerson
Journal:  Mol Cancer Res       Date:  2019-08-28       Impact factor: 5.852

2.  Synthetic Lethal Interaction of SHOC2 Depletion with MEK Inhibition in RAS-Driven Cancers.

Authors:  Rita Sulahian; Jason J Kwon; Katherine H Walsh; Emma Pailler; Timothy L Bosse; Maneesha Thaker; Diego Almanza; Joshua M Dempster; Joshua Pan; Federica Piccioni; Nancy Dumont; Alfredo Gonzalez; Jonathan Rennhack; Behnam Nabet; John A Bachman; Amy Goodale; Yenarae Lee; Mukta Bagul; Rosy Liao; Adrija Navarro; Tina L Yuan; Raymond W S Ng; Srivatsan Raghavan; Nathanael S Gray; Aviad Tsherniak; Francisca Vazquez; David E Root; Ari J Firestone; Jeff Settleman; William C Hahn; Andrew J Aguirre
Journal:  Cell Rep       Date:  2019-10-01       Impact factor: 9.423

3.  A Compendium of Genetic Modifiers of Mitochondrial Dysfunction Reveals Intra-organelle Buffering.

Authors:  Tsz-Leung To; Alejandro M Cuadros; Hardik Shah; Wendy H W Hung; Yang Li; Sharon H Kim; Daniel H F Rubin; Ryan H Boe; Sneha Rath; John K Eaton; Federica Piccioni; Amy Goodale; Zohra Kalani; John G Doench; David E Root; Stuart L Schreiber; Scott B Vafai; Vamsi K Mootha
Journal:  Cell       Date:  2019-11-14       Impact factor: 41.582

4.  Genes and compounds that increase type VII collagen expression as potential treatments for dystrophic epidermolysis bullosa.

Authors:  Elizabeth L Thompson; Michael Pickett-Leonard; Megan J Riddle; Weili Chen; Frank W Albert; Jakub Tolar
Journal:  Exp Dermatol       Date:  2022-03-09       Impact factor: 4.511

5.  Inactivation of NF1 Promotes Resistance to EGFR Inhibition in KRAS/NRAS/BRAFV600 -Wild-Type Colorectal Cancer.

Authors:  Alexandros Georgiou; Adam Stewart; David Cunningham; Udai Banerji; Steven R Whittaker
Journal:  Mol Cancer Res       Date:  2020-02-25       Impact factor: 5.852

6.  A Genome-scale CRISPR Screen Identifies the ERBB and mTOR Signaling Networks as Key Determinants of Response to PI3K Inhibition in Pancreatic Cancer.

Authors:  Charlotte K Milton; Annette J Self; Paul A Clarke; Udai Banerji; Federica Piccioni; David E Root; Steven R Whittaker
Journal:  Mol Cancer Ther       Date:  2020-05-05       Impact factor: 6.261

7.  Pooled CRISPR Screens in Drosophila Cells.

Authors:  Raghuvir Viswanatha; Roderick Brathwaite; Yanhui Hu; Zhongchi Li; Jonathan Rodiger; Pierre Merckaert; Verena Chung; Stephanie E Mohr; Norbert Perrimon
Journal:  Curr Protoc Mol Biol       Date:  2019-12

8.  Expediting rare disease diagnosis: a call to bridge the gap between clinical and functional genomics.

Authors:  Samantha N Hartin; John C Means; Joseph T Alaimo; Scott T Younger
Journal:  Mol Med       Date:  2020-11-25       Impact factor: 6.354

9.  PPM1D mutations are oncogenic drivers of de novo diffuse midline glioma formation.

Authors:  Prasidda Khadka; Zachary J Reitman; Sophie Lu; Graham Buchan; Gabrielle Gionet; Frank Dubois; Diana M Carvalho; Juliann Shih; Shu Zhang; Noah F Greenwald; Travis Zack; Ofer Shapira; Kristine Pelton; Rachel Hartley; Heather Bear; Yohanna Georgis; Spandana Jarmale; Randy Melanson; Kevin Bonanno; Kathleen Schoolcraft; Peter G Miller; Alexandra L Condurat; Elizabeth M Gonzalez; Kenin Qian; Eric Morin; Jaldeep Langhnoja; Leslie E Lupien; Veronica Rendo; Jeromy Digiacomo; Dayle Wang; Kevin Zhou; Rushil Kumbhani; Maria E Guerra Garcia; Claire E Sinai; Sarah Becker; Rachel Schneider; Jayne Vogelzang; Karsten Krug; Amy Goodale; Tanaz Abid; Zohra Kalani; Federica Piccioni; Rameen Beroukhim; Nicole S Persky; David E Root; Angel M Carcaboso; Benjamin L Ebert; Christine Fuller; Ozgun Babur; Mark W Kieran; Chris Jones; Hasmik Keshishian; Keith L Ligon; Steven A Carr; Timothy N Phoenix; Pratiti Bandopadhayay
Journal:  Nat Commun       Date:  2022-02-01       Impact factor: 17.694

10.  TRIM8 modulates the EWS/FLI oncoprotein to promote survival in Ewing sarcoma.

Authors:  Bo Kyung A Seong; Neekesh V Dharia; Shan Lin; Katherine A Donovan; Shasha Chong; Amanda Robichaud; Amy Conway; Amanda Hamze; Linda Ross; Gabriela Alexe; Biniam Adane; Behnam Nabet; Fleur M Ferguson; Björn Stolte; Emily Jue Wang; Jialin Sun; Xavier Darzacq; Federica Piccioni; Nathanael S Gray; Eric S Fischer; Kimberly Stegmaier
Journal:  Cancer Cell       Date:  2021-07-29       Impact factor: 31.743

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.